Valentin Fulga

Background

About Valentin Fulga

An experienced executive, a creative leader, a serial entrepreneur with over 20 years of experience in the life science industry and MD degree, I brought companies from inception to major value inflection. I am the inventor of over 50 issued and pending patents and the author of 15 scientific and medical articles. As co-founder of Hemostemix, a Canadian public company, I am the inventor of the technology and led the company’s activities from inception to enrolling patients in a multinational Ph 2 clinical trial. In 2003, I founded and led Theravitae from the scientific concept, which I devised, to receiving the 2006 Technology Pioneer Award from the World Economic Forum. As a delegate at the WEF Meeting in Davos, Switzerland, I moderated a regenerative medicine session. In 1997, I co-founded Proneuron Biotechnologies; one of the first cell therapy companies in the industry. As Senior VP of Development, I helped the company grow from early preclinical data in the academia to FDA-approved Ph 2 trials. I also co-founded Riolan Ophthalmics, a company focused on the re-purposing of a small molecule drug to a new ophthalmic indication. The company was sold to a drug development group. I gave numerous presentations at business, medical and scientific meetings and have been interviewed by prestigious journals and electronic media, such as Time, Red Herring, and Sixty Minutes. Skills: •Strong ability to lead groups of people towards common goals by inspiring them and gaining their confidence •Capacity to utilize existing resources to achieve highest goals possible effectively and efficiently •Entrepreneurial spirit, creative thinking and ability to define future industry trends •Capability to predict synergism of projects by using a comprehensive approach to evaluate them from business, scientific, clinical and regulatory angles •Excellent communication, negotiation and management skills Specialties: management, leadership, product development, IP strategy, licensing